Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Submitted by
admin
on September 30, 2011 - 11:09am
Source:
Yahoo/AP
News Tags:
Array
lung cancer
selumetinib
AstraZeneca
Headline:
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Do Not Allow Advertisers to Use My Personal information
